why choose us

First received: August 08, 2023

Clinical Trial: Neuromodulation for a Novel OCD Biomarker and Treatment

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: OCD

Study Type: INTERVENTIONAL


Official Title: Neuromodulation for a Novel OCD Biomarker and Treatment

Brief Summary: Although multiple treatments for OCD exist, slow symptom decrease, high remission, and significant side effects for some OCD patients limit their efficacy.More research into the precise neural mechanisms and linked cognitive functions in OCD is also necessary.To address both concerns, this study by Dr. Reinhart and his team will test a new, non-invasive, and well-tolerated neuromodulation method for reducing OCD symptoms, based on reward-related rhythms of the orbitofrontal cortex (OFC; a brain region responsible…

Read more